US EditionBiotech Firm Announces ‘Pivotal Step’ in Effort to Bring Back the Dodo
Colossal Biosciences raised $120 million, extending its Series C to $320 million and valuing the company at $10.3 billion to advance dodo bird de-extinction.
- Colossal Biosciences announced on September 17 that its scientists successfully grew pigeon primordial germ cells, a key step toward dodo revival in Texas.
- The achievement follows the company's 2021 founding and aims to use gene-edited surrogates like chickens to breed dodos, with critics noting limits to true resurrection.
- The company plans to inject edited cells from the Nicobar pigeon, the dodo's closest relative, into surrogate chickens and also targets the extinct moa bird.
- Colossal has raised $120 million more in funding, boosting its valuation past $10.3 billion, with CEO Ben Lamm describing the team's achievement as a major step forward for efforts to bring back the dodo.
- This progress supports plans for dodo rewilding in Mauritius, while the firm’s broader goals include advancing avian conservation and accelerating de-extinction projects.
62 Articles
62 Articles
Scientists edge closer to resurrecting extinct dodo bird - by using pigeon DNA
The dodo is one step closer to being resurrected thanks to a remarkable new genetic engineering experiment.Scientists have genetically "edited" chickens - which they could lay eggs containing the extinct bird.Colossal Biosciences, which just weeks ago announced plans to revive the long-dead giant Moa, is behind the breakthrough.The firm, a biotechnology and genetic engineering company in Texas, has managed to create chickens which do not have th…
Startup Gives Its Timeline for Breeding Actual Dodo Birds
To "go the way of the dodo" could come to mean something very different if Colossal Biosciences has its way. The Texas startup—founded in 2021 and bent on seeing the "de-extinction" of certain species —claims it has made a key advancement in its efforts to resurrect the bird , which...
Coverage Details
Bias Distribution
- 76% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
